Ifom

Ifom, established in 2000, is a prominent research institute dedicated to advancing the understanding of cancer mechanisms through multidisciplinary and international collaboration. Based in Milano, Italy, the organization operates as a non-profit entity focused on molecular oncology, bridging the gap between fundamental research and clinical application. By integrating advanced laboratory studies with innovative diagnostic development, Ifom plays a critical role in the global oncology landscape, providing essential insights into cellular behavior and therapeutic pathways.

The institute maintains a robust operational structure, supporting a workforce of 500-1,000 employees who drive its scientific mission. This diverse team includes researchers, scientists, and healthcare professionals working in specialized laboratories to translate complex molecular data into actionable medical solutions. Meet Ifom's team to understand the organizational expertise and leadership driving these high-impact research initiatives. The institute’s commitment to excellence is reflected in its rigorous training programs and its focus on fostering the next generation of oncology experts through comprehensive PhD opportunities.

Beyond its core research activities, Ifom actively engages in technology transfer to ensure that scientific breakthroughs reach clinical settings efficiently. The institute’s portfolio includes advanced cancer research, molecular diagnostics, and educational services, positioning it as a key player in the European medical research sector. With an annual revenue of $100.2M, Ifom continues to invest in cutting-edge infrastructure and collaborative projects, solidifying its reputation as a leader in the fight against cancer through scientific innovation and academic rigor.